Testosterone cypionate is an esterified form of the androgen testosterone, a naturally occurring steroid hormone primarily produced in the testes of males and in smaller amounts in the ovaries of females and adrenal glands in both sexes. As a medication, it is categorized as an androgen and an anabolic steroid. It is commonly administered via intramuscular injection and is designed for a sustained release of testosterone, providing a relatively stable level of the hormone over an extended period. This sustained-release property is due to the cypionate ester, which is slowly cleaved from the testosterone molecule *in vivo*, converting it into bioactive testosterone. The primary medical application of testosterone cypionate is in testosterone replacement therapy (TRT) for men diagnosed with hypogonadism, a condition characterized by insufficient testosterone production. It is also used in certain cases for delayed puberty in boys and for specific types of breast cancer in women. (Source: DrugBank, MedlinePlus)
Deep dive
Tap a section to expand.
Known interactions
Category rule: peptide × hormone
Note
Injectable peptides plus hormones can have overlapping or compounding effects that aren't always well characterized.
Track bloodwork with a provider; don't assume combinations are neutral.
Compound-pair rule
Synergy
AI manages estradiol on TRT.
Titrate AI to target mid-range E2 with bloodwork every 6–8 weeks.
Compound-pair rule
Synergy
HCG maintains intratesticular testosterone and testicular size during exogenous testosterone use.
Typical protocol: 250–500 IU HCG 2–3× weekly alongside TRT.
Compound-pair rule
Caution
5-alpha-reductase inhibitors block DHT conversion; can affect libido and prostate response on TRT.
Discuss goals with prescribing clinician; monitor sexual function.
Compound-pair rule
Caution
5-alpha-reductase inhibitors block DHT conversion; can affect libido and prostate response on TRT.
Discuss goals with prescribing clinician; monitor sexual function.
Compound-pair rule
Caution
5-alpha-reductase inhibitors block DHT conversion; can affect libido and prostate response on TRT.
Discuss goals with prescribing clinician; monitor sexual function.
Frequently asked
Sources referenced
["DrugBank","MedlinePlus","PubChem","Mayo Clinic","FDA prescribing information","Cochrane Review","NIH ODS (Office of Dietary Supplements)"]
Stackwise compiles summaries from publicly available scientific and regulatory references. Always verify important decisions with a licensed clinician.
Related compounds
Others in the hormone category or studied for the same goals.